Transdermal clonidine in patients with swallowing dysfunction

Area of Science:

• Palliative Care
• Pharmacology
• Neurology

Background:

• Patients with swallowing dysfunction often experience significant oropharyngeal secretion accumulation.
• Managing these secretions presents a substantial challenge for healthcare teams, impacting patient care and resource allocation.

Purpose of the Study:

• To evaluate the efficacy and tolerability of transdermal clonidine film in managing oropharyngeal secretions in patients with swallowing dysfunction.
• To assess the impact of transdermal clonidine on medical staff workload.

Main Methods:

• A case series of 10 patients with swallowing dysfunction was treated with transdermal clonidine film.
• Data on secretion control, tolerability, and staff effort were collected.

Main Results:

• Transdermal clonidine film application was well tolerated by all patients.
• The treatment provided rapid and effective control of oropharyngeal secretions.
• A notable reduction in the labor required by medical staff was observed.

Conclusions:

• Transdermal clonidine film is a promising antisialogogue for patients with swallowing dysfunction.
• The physiological properties of clonidine support its use in reducing salivary secretions.
• This therapeutic approach can improve patient management and alleviate healthcare provider burden.